Table 2. Prevalence of symptoms experienced by patients before and after treatment in the intervention and control groups.
| Symptoms | Pre-intervention, n (%) | p-value | Post-intervention, n (%) | p-value | ||
|---|---|---|---|---|---|---|
| Cryo-placebo | Cryotherapy | Cryo-placebo | Cryotherapy | |||
| Leucorrhea | 66 (88.0) | 61 (80.3) | 0.141 | 57 (76.0) | 42 (55.3) | 0.006 |
| Vaginal itching and pruritus | 56 (74.7) | 49 (64.5) | 0.118 | 38 (50.7) | 15 (19.7) | < 0.001 |
| Pelvic pain | 51 (68.0) | 52 (68.4) | 0.547 | 40 (53.3) | 25 (32.9) | 0.009 |
| Dyspareunia | 45 (60.0) | 47 (61.8) | 0.474 | 37 (49.3) | 21 (27.6) | 0.005 |
| Post-coital bleeding | 33 (44.0) | 37 (48.7) | 0.340 | 18 (24.0) | 8 (10.5) | 0.023 |
Fisher’s exact test.